FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

isaac veinbergs

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Physiology

Maze Learning

Disorders

Activities & Behaviors

Animal Behavior

Co-author Network

Publications

TOP 3
Kimberly E Vanover; isaac veinbergs; Robert E Davis
Antipsychotic-like behavioral effects and cognitive enhancement by a potent and selective muscarinic M-sub-1 receptor agonist, AC-260584.
Luis R Gardell; Kimberly E Vanover; Linda Pounds; Robert W Johnson; Richard Barido; Gary T Anderson; isaac veinbergs; Agnete Dyssegaard; Per Brunmark; Ali Tabatabaei; Robert E Davis; Mark R Brann; Uli Hacksell; Douglas W Bonhaus
ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
Kimberly E Vanover; David M Weiner; Malath Makhay; isaac veinbergs; Luis R Gardell; Jelveh Lameh; Andria L Del Tredici; Fabrice Piu; Hans H Schiffer; Thomas R Ott; Ethan S Burstein; Allan K Uldam; Mikkel B Thygesen; Nathalie Schlienger; Carl Magnus Andersson; Thomas Y Son; Scott C Harvey; Susan B Powell; Mark A Geyer; Bo-Ragnar Tolf; Mark R Brann; Robert E Davis
Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of isaac veinbergs (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Kimberly E Vanover; isaac veinbergs; Robert E Davis
Antipsychotic-like behavioral effects and cognitive enhancement by a potent and selective muscarinic M-sub-1 receptor agonist, AC-260584.
Behavioral neuroscience 2008;122(3):570-5.
2007: Luis R Gardell; Kimberly E Vanover; Linda Pounds; Robert W Johnson; Richard Barido; Gary T Anderson; isaac veinbergs; Agnete Dyssegaard; Per Brunmark; Ali Tabatabaei; Robert E Davis; Mark R Brann; Uli Hacksell; Douglas W Bonhaus
ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
The Journal of pharmacology and experimental therapeutics 2007;322(2):862-70.
2006: Kimberly E Vanover; David M Weiner; Malath Makhay; isaac veinbergs; Luis R Gardell; Jelveh Lameh; Andria L Del Tredici; Fabrice Piu; Hans H Schiffer; Thomas R Ott; Ethan S Burstein; Allan K Uldam; Mikkel B Thygesen; Nathalie Schlienger; Carl Magnus Andersson; Thomas Y Son; Scott C Harvey; Susan B Powell; Mark A Geyer; Bo-Ragnar Tolf; Mark R Brann; Robert E Davis
Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist.
The Journal of pharmacology and experimental therapeutics 2006;317(2):910-8.
2004: David M Weiner; Herbert Y Meltzer; isaac veinbergs; E M Donohue; Tracy A Spalding; T T Smith; Nina Mohell; Scott C Harvey; Jelveh Lameh; Norman R Nash; Kimberly E Vanover; Roger Olsson; K Jayathilake; Michael K Lee; Allan Levey; Uli Hacksell; Ethan S Burstein; Robert E Davis; Mark R Brann
The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine.
Psychopharmacology 2004;177(1-2):207-16.
2004: Kimberly E Vanover; Scott C Harvey; Thomas Son; Stefania Risso Bradley; Henriette Kold; Malath Makhay; isaac veinbergs; Tracy A Spalding; David M Weiner; Carl Magnus Andersson; Bo-Ragnar Tolf; Mark R Brann; Uli Hacksell; Robert E Davis
Pharmacological characterization of AC-90179 [2-(4-methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide hydrochloride]: a selective serotonin 2A receptor inverse agonist.
The Journal of pharmacology and experimental therapeutics 2004;310(3):943-51.
2002: Emily Van Uden; Margaret Mallory; isaac veinbergs; Michael Alford; Edward Rockenstein; Eliezer Masliah
Increased extracellular amyloid deposition and neurodegeneration in human amyloid precursor protein transgenic mice deficient in receptor-associated protein.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(21):9298-304.
2002: isaac veinbergs; Analisa Everson; Yutaka Sagara; Eliezer Masliah
Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis.
Journal of neuroscience research 2002;67(3):379-87.
2001: Eliezer Masliah; Edward Rockenstein; isaac veinbergs; Yutaka Sagara; Margaret Mallory; Makoto Hashimoto; Lennart Mucke
beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(21):12245-50.
2001: isaac veinbergs; Emily Van Uden; Margaret Mallory; Michael Alford; C McGiffert; RM DeTeresa; R Orlando; Eliezer Masliah
Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.
Experimental neurology 2001;170(1):15-26.
2000: isaac veinbergs; Margaret Mallory; Yutaka Sagara; Eliezer Masliah
Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice.
The European journal of neuroscience 2000;12(12):4541-6.
2000: Eliezer Masliah; Edward Rockenstein; isaac veinbergs; Margaret Mallory; Makoto Hashimoto; A Takeda; Yutaka Sagara; Abbyann Sisk; Lennart Mucke
Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.
Science (New York, N.Y.) 2000;287(5456):1265-9.
2000: isaac veinbergs; Michael Mante; Margaret Mallory; Eliezer Masliah
Neurotrophic effects of Cerebrolysin in animal models of excitotoxicity.
Journal of neural transmission. Supplementum 2000;59():273-80.
1999: Federico Licastro; I L Campbell; C Kincaid; isaac veinbergs; Emily Van Uden; Edward Rockenstein; Margaret Mallory; John Gilbert; Eliezer Masliah
A role for apoE in regulating the levels of alpha-1-antichymotrypsin in the aging mouse brain and in Alzheimer's disease.
The American journal of pathology 1999;155(3):869-75.
1999: isaac veinbergs; Margaret Mallory; Michael Mante; Edward Rockenstein; John Gilbert; Eliezer Masliah
Differential neurotrophic effects of apolipoprotein E in aged transgenic mice.
Neuroscience letters 1999;265(3):218-22.
1999: isaac veinbergs; Michael Mante; M W Jung; Emily Van Uden; Eliezer Masliah
Synaptotagmin and synaptic transmission alterations in apolipoprotein E-deficient mice.
Progress in neuro-psychopharmacology & biological psychiatry 1999;23(3):519-31.
1999: Eliezer Masliah; F Armasolo; isaac veinbergs; Margaret Mallory; W Samuel
Cerebrolysin ameliorates performance deficits, and neuronal damage in apolipoprotein E-deficient mice.
Pharmacology, biochemistry, and behavior 1999;62(2):239-45.
1999: Emily Van Uden; isaac veinbergs; Margaret Mallory; R Orlando; Eliezer Masliah
A novel role for receptor-associated protein in somatostatin modulation: implications for Alzheimer's disease.
Neuroscience 1999;88(3):687-700.
1999: isaac veinbergs; Eliezer Masliah
Synaptic alterations in apolipoprotein E knockout mice.
Neuroscience 1999;91(1):401-3.
1998: Leigh J Hsu; Margaret Mallory; Y Xia; isaac veinbergs; Makoto Hashimoto; M Yoshimoto; Leon J Thal; T Saitoh; Eliezer Masliah
Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development.
Journal of neurochemistry 1998;71(1):338-44.
1998: isaac veinbergs; M W Jung; SJ Young; Emily Van Uden; P M Groves; Eliezer Masliah
Altered long-term potentiation in the hippocampus of apolipoprotein E-deficient mice.
Neuroscience letters 1998;249(2-3):71-4.
1997: Eliezer Masliah; W Samuel; isaac veinbergs; Margaret Mallory; Michael Mante; T Saitoh
Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE.
Brain research 1997;751(2):307-14.
1996: Eliezer Masliah; Margaret Mallory; isaac veinbergs; A Miller; W Samuel
Alterations in apolipoprotein E expression during aging and neurodegeneration.
Progress in neurobiology 1996;50(5-6):493-503.
1995: Eliezer Masliah; Margaret Mallory; N Ge; Michael Alford; isaac veinbergs; Allen D Roses
Neurodegeneration in the central nervous system of apoE-deficient mice.
Experimental neurology 1995;136(2):107-22.
1994: J M Roch; Eliezer Masliah; A C Roch-Levecq; M Sundsmo; D A Otero; isaac veinbergs; T Saitoh
Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(16):7450-4.